Pixium Vision SA engages in the development of innovative retinal implant systems specializing in sensory neuromodulation. Its products include Intelligent Retinal Implant Systems and PRIMA system. The IRIS treats patients who have lost their sight through degenerative conditions of the eye such as retinitis pigmentosa, other retinal dystrophies or age-related macular degeneration. The PRIMA system is designed to enable physiological signal processing, while simplifying the surgical procedure. The company was founded on Jose-Alain Sahel, Bernard Gilly, Serge Picaud, Christoph Posch, Philippe Bergonzo and Lionel Rousseau on December 28, 2011 and is headquartered in Paris, France.